ABSTRACT:
Tuberculosis incidences are increasing by nearly 6.6% every year. Tuberculosis are associated with HIV/AIDS approximately 32% of cases. Objective: The purpose of this study to understand the cause, clinical manifestations and treatment course for Tuberculosis. Material and methods: detailed clinical history and physical examination was done. All the pertinent investigations were studied thoroughly of the selected case. Results: the Tuberculosis is confirmed with the help of Tuberculin Skin Test, chest X ray: Significant cavities found and Sputum AFB+ Conclusion: Tuberculosis is the serious infectious bacterial disease that mainly affects the lungs Tuberculin Skin Test, chest X ray and Sputum AFB are the diagnostics methods. The prognosis is depend usually better if treatment received on time.
Cite this article:
Manthankumar N. Kapadiya. Tuberculosis Case Study. Int. J. of Advances in Nur. Management. 2021; 9(2):160-161. doi: 10.5958/2454-2652.2021.00036.6
Cite(Electronic):
Manthankumar N. Kapadiya. Tuberculosis Case Study. Int. J. of Advances in Nur. Management. 2021; 9(2):160-161. doi: 10.5958/2454-2652.2021.00036.6 Available on: https://ijanm.com/AbstractView.aspx?PID=2021-9-2-8
REFERENCES:
1. World Health Organization (WHO), Multidrug-resistant Tuberculosis (MDR-TB) [Online] Accessed: 03 June 2014.
2. Tenover FC, Crawford JT, Huebner RE, et al. (1993) The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 31:767–770.
3. WHO, TB diagnostics and laboratory strengthening - WHO policy. The use of liquid medium for culture and DST, 2007. [Online] Accessed: 03 June 2014. Available at: http://www.who.int/tb/laboratory/policy_liquid_medium_for_culture_dst/en/index.html?Utm_source=feedblitz&utm_medium=feedblitzemail &utm_content=565123&utm_campaign=Twelve-hourly_%272011-08-10%2000%3A00%3A00%27
4. WHO (2010) WHO endorses new rapid tuberculosis test. [Online] Accessed: 03 June 2014. Available at: http://www.who.int/mediacentre/news/releases/2010/tb_test_20101208/en/
5. Boehme, C.C., Nabeta, P., Hilleman, D. Et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. New Eng J Med. 363: 1005-15.
6. Miotto, P., Cabibbe, A.M., Manteganai, P. Et al. (2012) genotype mtbdrsl performance on clinical samples with diverse genetic background. Eur Respir J. 40:690-8.
7. Lawn, S.D., Kerkhoff, A.D., Vogt, M., Wood, R. (2008) Diagnostic accuracy of a low-cost urine antigen, point of care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: A descriptive study. Lancet Infect Dis. 2012 1293): 201-97.
8. Ling, D.I., Zwerling, A., Pai, M. (2008) genotype MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 32:1165-74.
9. Dheda, K, Ruhwald, M., Theron, G. Et al. (2013) Point-of-care diagnosis of tuberculosis: Past, present and future. Respirol. 18: 217-232.
10. Mitnick, C.D., Shin, S.S., Seung, K.J. et al. (2008) Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 359: 563–74.